IRIS
MALAGNINO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.759
AS - Asia 3.188
EU - Europa 2.590
Continente sconosciuto - Info sul continente non disponibili 492
SA - Sud America 481
AF - Africa 64
OC - Oceania 16
Totale 15.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.545
SG - Singapore 1.382
IT - Italia 1.016
CN - Cina 506
BR - Brasile 364
RU - Federazione Russa 350
HK - Hong Kong 325
VN - Vietnam 262
BD - Bangladesh 240
DE - Germania 208
IE - Irlanda 163
GB - Regno Unito 141
CA - Canada 117
FI - Finlandia 117
JP - Giappone 107
SE - Svezia 107
KR - Corea 101
FR - Francia 98
NL - Olanda 89
PL - Polonia 72
IN - India 71
ES - Italia 63
UA - Ucraina 46
MX - Messico 42
AR - Argentina 41
ID - Indonesia 40
TR - Turchia 36
AT - Austria 34
IQ - Iraq 29
CO - Colombia 28
ZA - Sudafrica 20
JM - Giamaica 19
PH - Filippine 17
CZ - Repubblica Ceca 16
EC - Ecuador 16
BE - Belgio 11
CR - Costa Rica 11
PK - Pakistan 11
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 9
IL - Israele 9
AU - Australia 8
LT - Lituania 8
NZ - Nuova Zelanda 8
MA - Marocco 7
NG - Nigeria 7
SA - Arabia Saudita 7
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
UZ - Uzbekistan 6
DZ - Algeria 5
JO - Giordania 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
BB - Barbados 4
HN - Honduras 4
HR - Croazia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
IR - Iran 3
NP - Nepal 3
PE - Perù 3
PR - Porto Rico 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
DK - Danimarca 2
EU - Europa 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
Totale 15.095
Salva come PNG Salva come JPEG
Città #
Wilmington 1.356
Houston 911
Woodbridge 848
Singapore 789
San Jose 580
Ashburn 488
Rome 324
Hong Kong 319
Chandler 284
Fairfield 284
Council Bluffs 262
New York 260
Beijing 196
Los Angeles 170
Santa Clara 131
Dublin 120
Seattle 118
Ann Arbor 113
Cambridge 106
Tokyo 104
Ho Chi Minh City 103
The Dalles 90
Helsinki 87
Milan 84
Buffalo 70
Dallas 69
Medford 67
Hanoi 64
Munich 61
Denver 60
Moscow 48
Nuremberg 45
São Paulo 43
London 36
Lawrence 33
Lauterbourg 32
Montreal 32
Chicago 31
San Diego 31
Orem 30
Dearborn 29
Naples 29
Toronto 29
Washington 29
Brooklyn 28
Kraków 28
Frankfurt am Main 27
Atlanta 25
Warsaw 25
Engelhard 24
North Bergen 23
Jakarta 22
Mexico City 22
Phoenix 21
Chennai 20
Lappeenranta 20
Jacksonville 19
Stockholm 19
Amsterdam 18
Madrid 17
Redondo Beach 17
Roebling 17
Boardman 16
Genoa 16
San Francisco 16
Colorado Springs 15
Florence 15
Manchester 15
Creede 14
Kingston 14
Vienna 14
Seoul 13
Bari 12
Ankara 11
Johannesburg 11
Palo Alto 11
St. George 11
Turin 11
Brussels 10
Mumbai 10
Palermo 10
Philadelphia 10
Poplar 10
Belo Horizonte 9
Brasília 9
Brno 9
Las Vegas 9
Menlo Park 9
Paris 9
Quito 9
Rio de Janeiro 9
San José 9
St Louis 9
Auckland 8
Barcelona 8
Bogotá 8
Da Nang 8
Elk Grove Village 8
Guangzhou 8
La Veta 8
Totale 9.798
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 593
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 593
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 490
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 392
NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells 385
Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy 372
Brief report: L-selectin (CD62L) is downregulated on CD4+ and CD8+ T lymphocytes of HIV-1-infected individuals naive for ART 359
Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART 359
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 351
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 336
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy 307
Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report 295
Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A case report 262
HIV MDR is still a relevant issue despite its dramatic drop over the years 262
Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards 242
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment 225
Virological reactivation of hepatitis B virus is a frequent event in anti-HBc-positive/HBsAg-negative HIV-infected patients switching to Tenofovir-sparing therapy as revealed by highly-sensitive HBV assays. 221
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients 201
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 192
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 192
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 191
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 182
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 170
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 167
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 160
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 157
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 156
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 155
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 148
Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department 145
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 144
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 144
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 141
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 139
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 138
New markers in monitoring the reactivation of hepatitis B virus infection in immunocompromised hosts 137
HBV infection in HIV-driven immune suppression 135
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 135
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors 130
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 130
for the Icona Foundation Study Group Reactivation of hepatitis B virus is a frequent event in anti-HBc-positive/HBsAg-negative HIV-infected patients switching to Tenofovir sparing therapy as revealed by highly sensitive HBV assays. 129
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 124
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 123
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 122
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 120
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 118
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 117
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 117
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 116
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 111
Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance 111
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 110
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 110
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 110
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 107
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study 105
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 104
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 103
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 103
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 102
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 100
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 99
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 99
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 99
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort 99
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 97
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 94
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 93
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis 93
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 92
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy 91
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 90
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 89
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 89
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 88
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 88
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 85
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 85
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 81
Total HIV DNA and cell-associated HIV RNA viral reservoirs in PBMCs and GALT in patients on triple-ART and switching to dual-ART regimens. 80
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 80
HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch 78
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 76
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 76
The transactivation of endogenous retroviruses correlates with HIV reservoir, lymphocytes activation and low CD4 count in virologically suppressed patients 74
null 74
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 73
Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements 71
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWH 70
Infezione da virus dell’epatite B correlati con l’infezione da Virus dell’Immunodeficienza Umana (HIV) 68
New insights into hepatitis B virus lymphotropism: implications for HBV-related lymphomagenesis 68
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 67
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 66
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy 64
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 64
COVID ‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features 63
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review 59
COVID-19 and influenza vaccination among adults stably engaged in HIV care 51
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 49
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 47
Totale 15.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022464 0 0 0 41 4 60 28 60 115 41 18 97
2022/2023908 72 69 158 95 75 159 73 73 58 4 44 28
2023/2024671 74 19 62 52 30 111 39 31 29 107 33 84
2024/20252.439 78 378 242 170 101 190 270 141 260 201 211 197
2025/20265.106 473 201 411 453 436 224 676 551 620 426 339 296
2026/20271.791 350 255 813 373 0 0 0 0 0 0 0 0
Totale 15.590